The Patent Finder

Composition Comprising a Mixture of Dextro -And Levo-Amphetamines Complexed with Ion-Exchange Resin Particles to Form Drug Resin Particles

Neos Therapeutics, LP

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 6 of these applications claim priority to application PCT/US2012/044698, filed Jun 28, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 8,709,491Composition Comprising a Mixture of Dextro- and Levo- Amphetamines Complexed with Ion-Exchange Resin Particles to Form Drug Resin Particles
In force
 · High confidence
UsedRemaining
Neos Therapeutics, LPIn forceHigh confidence
US 9,017,731Composition Comprising a Mixture of Dextro -And Levo-Amphetamines Complexed with Ion-Exchange Resin Particles to Form Drug Resin Particles
In force
 · High confidence
Neos Therapeutics, LPIn forceHigh confidence
US 9,072,680Compositions Comprising Methylphenidate Complexed with Ion-Exchange Resin Particles
In force
 · High confidence
Neos Therapeutics, LPIn forceHigh confidence
US 9,089,496Compositions Comprising Methylphenidate Complexed with Ion-Exchange Resin Particles
In force
 · High confidence
Neos Therapeutics, LPIn forceHigh confidence
US 9,265,737Pharmaceutical Composition Comprising Amphetamines Complexed with Ion-Exchange Resin Particles
In force
 · High confidence
Neos Therapeutics, LPIn forceHigh confidence
US 9,839,619Method for Treating Add or Adhd Comprising Administering Amphetamine Complexed with Ion-Exchange Resin Particles
In force
 · High confidence
Neos Therapeutics LPIn forceHigh confidence
Application 13/844,510Method for reducing the effects of an elevated exposure to methyphenidate in presence of ethanol by using a composition comprising methylphenidate complexed with ion-exchange resin particles
Abandoned
Abandoned Aug 17, 2020
Neos Therapeutics LPAbandonedAbandoned Aug 17, 2020
Application 13/844,628Dosage Forms for Oral Administration and Methods of Treatment Using the Same
Abandoned
Abandoned Oct 28, 2019
Neos Therapeutics, LPAbandonedAbandoned Oct 28, 2019
Application 13/947,861Treating Add or Adhd with a Composition Comprising Methylphenidate Complexed with Ion-Exchange Resin Particles
Abandoned
Abandoned Aug 17, 2020
Neos Therapeutics, LPAbandonedAbandoned Aug 17, 2020
Application 13/947,897Dosage Forms for Oral Administration and Methods of Treatment Using the Same
Abandoned
Abandoned Jun 28, 2019
Neos Therapeutics, LPAbandonedAbandoned Jun 28, 2019
10 of 10 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
6 of these are in force and held by Neos Therapeutics, LP.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited